Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bolla

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Acta Oncologica (Stockholm, Sweden)|June 24, 2008
Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladderPhilip M Poortmans, Pierre Richaud, Laurence Collette, et al.
Current Topics in Medicinal Chemistry|July 10, 2010
Efflux pumps of gram-negative bacteria, a new target for new moleculesJean-Marie Pagès, Alibert-Franco Sandrine, Abdallah Mahamoud, et al.
Archiv Der Pharmazie|May 18, 2023
Synthesis and antimicrobial testing of 5-fluorouracil derivativesMrunal Patil, Krykun Serhii, Frédéric Garzino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2006
Guidelines for primary radiotherapy of patients with prostate cancerDirk Boehmer, Philippe Maingon, Philip Poortmans, et al.
European Urology|November 1, 2011
Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomyAndrew J Stephenson, Michel Bolla, Alberto Briganti, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2010
Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyroneVictor Kuete, Bathélémy Ngameni, Jean G Tangmouo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2013
Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedurePaul A Fenton, Coen Hurkmans, Akos Gulyban, et al.
Medical Physics|July 21, 2004
MRI/TRUS data fusion for prostate brachytherapy. Preliminary resultsChristophe Reynier, Jocelyne Troccaz, Philippe Fourneret, et al.
Plos One|May 13, 2009
How beta-lactam antibiotics enter bacteria: a dialogue with the porinsChloë E James, Kozhinjampara R Mahendran, Alexander Molitor, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991Fatma Ataman, Philip Poortmans, J Bernard Davis, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Acta Oncologica (Stockholm, Sweden)|June 24, 2008
Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladderPhilip M Poortmans, Pierre Richaud, Laurence Collette, et al.
Current Topics in Medicinal Chemistry|July 10, 2010
Efflux pumps of gram-negative bacteria, a new target for new moleculesJean-Marie Pagès, Alibert-Franco Sandrine, Abdallah Mahamoud, et al.
Archiv Der Pharmazie|May 18, 2023
Synthesis and antimicrobial testing of 5-fluorouracil derivativesMrunal Patil, Krykun Serhii, Frédéric Garzino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2006
Guidelines for primary radiotherapy of patients with prostate cancerDirk Boehmer, Philippe Maingon, Philip Poortmans, et al.
European Urology|November 1, 2011
Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomyAndrew J Stephenson, Michel Bolla, Alberto Briganti, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2010
Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyroneVictor Kuete, Bathélémy Ngameni, Jean G Tangmouo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2013
Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedurePaul A Fenton, Coen Hurkmans, Akos Gulyban, et al.
Medical Physics|July 21, 2004
MRI/TRUS data fusion for prostate brachytherapy. Preliminary resultsChristophe Reynier, Jocelyne Troccaz, Philippe Fourneret, et al.
Plos One|May 13, 2009
How beta-lactam antibiotics enter bacteria: a dialogue with the porinsChloë E James, Kozhinjampara R Mahendran, Alexander Molitor, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991Fatma Ataman, Philip Poortmans, J Bernard Davis, et al.
Pageof 16